Miller KD - Search Results

1

Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?

Partridge AH, Sepucha K, O'Neill A, Miller KD, Baker E, Dang CT, Northfelt DW, Sledge GW, Schneider BP. Partridge AH, et al. Among authors: miller kd. Breast Cancer Res Treat. 2017 Oct;165(3):545-553. doi: 10.1007/s10549-017-4338-x. Epub 2017 Jun 23. Breast Cancer Res Treat. 2017. PMID: 28646344 Free PMC article.

2

Taxanes in the treatment of breast cancer: a prodigy comes of age.

Miller KD, Sledge GW Jr. Miller KD, et al. Cancer Invest. 1999;17(2):121-36. Cancer Invest. 1999. PMID: 10071597 Review.

3

Metastatic breast cancer: the role of chemotherapy.

Sledge GW Jr, Miller KD. Sledge GW Jr, et al. Among authors: miller kd. Semin Oncol. 1999 Feb;26(1 Suppl 2):6-10. Semin Oncol. 1999. PMID: 10190779 Review.

4

The role of chemotherapy for metastatic breast cancer.

Miller KD, Sledge GW Jr. Miller KD, et al. Hematol Oncol Clin North Am. 1999 Apr;13(2):415-34. doi: 10.1016/s0889-8588(05)70063-0. Hematol Oncol Clin North Am. 1999. PMID: 10363138 Review.

5

Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hoosier Oncology Group.

Miller KD, McCaskill-Stevens W, Sisk J, Loesch DM, Monaco F, Seshadri R, Sledge GW Jr. Miller KD, et al. J Clin Oncol. 1999 Oct;17(10):3033-7. doi: 10.1200/JCO.1999.17.10.3033. J Clin Oncol. 1999. PMID: 10506597 Clinical Trial.

6

Toward checkmate: biology and breast cancer therapy for the new millennium.

Miller KD, Sledge GW Jr. Miller KD, et al. Invest New Drugs. 1999;17(4):417-27. doi: 10.1023/a:1006311227965. Invest New Drugs. 1999. PMID: 10759407 Review.

7

Breast cancer: challenges and opportunities.

Sledge GW Jr, Miller K. Sledge GW Jr, et al. Semin Oncol. 1999 Dec;26(6 Suppl 18):1-5. Semin Oncol. 1999. PMID: 10892573 Review.

8

High-dose chemotherapy in breast cancer -- the perils of history uncontrolled.

Miller KD, Sledge GW Jr. Miller KD, et al. Medscape Womens Health. 2000 May-Jun;5(3):E1. Medscape Womens Health. 2000. PMID: 11109042 Review.

9

Redefining the target: chemotherapeutics as antiangiogenics.

Miller KD, Sweeney CJ, Sledge GW Jr. Miller KD, et al. J Clin Oncol. 2001 Feb 15;19(4):1195-206. doi: 10.1200/JCO.2001.19.4.1195. J Clin Oncol. 2001. PMID: 11181686 Review.

10

Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.

Miller KD, Sisk J, Ansari R, Gize G, Nattam S, Pennington K, Monaco F, Sledge GW Jr. Miller KD, et al. Oncology (Williston Park). 2001 Feb;15(2 Suppl 3):38-40. Oncology (Williston Park). 2001. PMID: 11252888 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters